Biology

Understanding of the peripheral immune system in MS 2:53
Understanding of the peripheral immune system in MS
João José Cerqueira • 27 Apr 2023
The circadian rhythm in health and disease 3:41
The circadian rhythm in health and disease
Michelle Jonelis • 27 Apr 2023
Occurrence of PIRA in RRMS: current understanding 2:02
Occurrence of PIRA in RRMS: current understanding
João José Cerqueira • 27 Apr 2023
Biological subtyping: the future of neurodegenerative diseases 2:44
Biological subtyping: the future of neurodegenerative diseases
Alberto Espay • 27 Apr 2023
Anti-obesity drugs increase adult neurogenesis in the hypothalamus 5:17
Anti-obesity drugs increase adult neurogenesis in the hypothalamus
David Petrik • 25 Apr 2023
Glycation of α-synuclein in Parkinson’s disease 2:02
Glycation of α-synuclein in Parkinson’s disease
Tiago Outeiro • 25 Apr 2023
Extracellular vesicles in Parkinson’s disease 3:00
Extracellular vesicles in Parkinson’s disease
Tiago Outeiro • 25 Apr 2023
MS therapies: limited direct effect in CNS pathology 2:29
MS therapies: limited direct effect in CNS pathology
Augusto A. Miravalle • 5 May 2023
The promise of proteomics in sleep medicine 2:07
The promise of proteomics in sleep medicine
Emmanuel Mignot • 11 May 2023
Developing a gene therapy for focal cortical dysplasia type II 4:41
Developing a gene therapy for focal cortical dysplasia type II
Amanda Almacellas • 24 Apr 2023
What is a tauopathy? 1:59
What is a tauopathy?
Boyd Ghosh • 20 Apr 2023
What is the significance of gastrointestinal involvement in Parkinson’s disease? 1:44
What is the significance of gastrointestinal involvement in Parkinson’s disease?
Dag Nyholm • 24 Mar 2023
Novel brain penetrant capsids for Parkinson’s disease gene therapy 2:37
Novel brain penetrant capsids for Parkinson’s disease gene therapy
Todd Carter • 29 Mar 2023
Main treatment targets in Parkinson’s disease clinical research 1:25
Main treatment targets in Parkinson’s disease clinical research
Gennaro Pagano • 5 Apr 2023
Developing antibodies against pathogenic TDP-43 in ALS 3:42
Developing antibodies against pathogenic TDP-43 in ALS
Johanne Kaplan • 30 Mar 2023
Developing antibodies to prevent pathological tau spreading in Alzheimer’s disease 3:14
Developing antibodies to prevent pathological tau spreading in Alzheimer’s disease
Todd Carter • 29 Mar 2023
The content of VJNeurology is intended for healthcare professionals